In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
The company has poor fundamentals for a short-term investment strategy.
Strengths
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The stock is in a well-established, long-term rising trend above the technical support level at 25.79 USD
Weaknesses
The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
The company does not generate enough profits, which is an alarming weak point.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 1084.44 times its estimated earnings per share for the ongoing year.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
For the past year, analysts have significantly revised downwards their profit estimates.